A randomised, double-blind, placebo-controlled, phase III trial to study the effect of irbesartan on endothelial function of the retinal vasculature in patients with hypercholesterolemia

Trial Profile

A randomised, double-blind, placebo-controlled, phase III trial to study the effect of irbesartan on endothelial function of the retinal vasculature in patients with hypercholesterolemia

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Cerebral ischaemia; Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Nov 2016 Results assessing effect of Valsartan on retinal capillary rarefaction in hypertensive patients (n=150) using patients data from this and other two trials (NCT01318395 and NCT01319344) published in the Journal of Clinical Hypertension (Greenwich)
    • 03 Feb 2010 Actual initiation date (Nov 2009) added as reported by ClinicalTrials.gov
    • 19 Jan 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top